Be Prepared to Switch Patients to New Fluticasone/Salmeterol Inhalers

July 2017

New fluticasone/salmeterol inhalers for asthma (AirDuo, etc) will compete with Advair...and lead to questions about how to switch.

Teva is launching AirDuo (air-DOO-oh) RespiClick AND its generic, fluticasone/salmeterol, at the same time. The generic costs about $90/month...versus $285/month for AirDuo or up to $475/month for Advair.

But the new dry-powder inhalers are NOT generics for Advair Diskus because they come in different strengths and devices. Plus AirDuo is not approved for COPD...and it's only for ages 12 and up.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote